Global Hospital-acquired Urinary Tract Infection Testing Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Hospital-acquired Urinary Tract Infection Testing Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Product
  • 1.4.2 Assay kits and consumables
  • 1.4.3 Instruments
• 1.5 Market by End User
  • 1.5.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by End User
  • 1.5.2 Hospitals and outpatient department
  • 1.5.3 Diagnostics clinical laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size
  • 2.1.1 Global Hospital-acquired Urinary Tract Infection Testing Revenue 2014-2025
  • 2.1.2 Global Hospital-acquired Urinary Tract Infection Testing Sales 2014-2025
• 2.2 Hospital-acquired Urinary Tract Infection Testing Growth Rate by Regions
  • 2.2.1 Global Hospital-acquired Urinary Tract Infection Testing Sales by Regions
  • 2.2.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Hospital-acquired Urinary Tract Infection Testing Sales by Manufacturers
  • 3.1.1 Hospital-acquired Urinary Tract Infection Testing Sales by Manufacturers
  • 3.1.2 Hospital-acquired Urinary Tract Infection Testing Sales Market Share by Manufacturers
  • 3.1.3 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio (CR5 and HHI)
• 3.2 Hospital-acquired Urinary Tract Infection Testing Revenue by Manufacturers
  • 3.2.1 Hospital-acquired Urinary Tract Infection Testing Revenue by Manufacturers (2014-2019)
  • 3.2.2 Hospital-acquired Urinary Tract Infection Testing Revenue Share by Manufacturers (2014-2019)
• 3.3 Hospital-acquired Urinary Tract Infection Testing Price by Manufacturers
• 3.4 Hospital-acquired Urinary Tract Infection Testing Manufacturing Base Distribution, Product Types
  • 3.4.1 Hospital-acquired Urinary Tract Infection Testing Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Hospital-acquired Urinary Tract Infection Testing Product Type
  • 3.4.3 Date of International Manufacturers Enter into Hospital-acquired Urinary Tract Infection Testing Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Hospital-acquired Urinary Tract Infection Testing Sales by Product
• 4.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue by Product
• 4.3 Hospital-acquired Urinary Tract Infection Testing Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Hospital-acquired Urinary Tract Infection Testing Breakdown Data by End User

6 North America

• 6.1 North America Hospital-acquired Urinary Tract Infection Testing by Countries
  • 6.1.1 North America Hospital-acquired Urinary Tract Infection Testing Sales by Countries
  • 6.1.2 North America Hospital-acquired Urinary Tract Infection Testing Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Hospital-acquired Urinary Tract Infection Testing by Product
• 6.3 North America Hospital-acquired Urinary Tract Infection Testing by End User

7 Europe

• 7.1 Europe Hospital-acquired Urinary Tract Infection Testing by Countries
  • 7.1.1 Europe Hospital-acquired Urinary Tract Infection Testing Sales by Countries
  • 7.1.2 Europe Hospital-acquired Urinary Tract Infection Testing Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Hospital-acquired Urinary Tract Infection Testing by Product
• 7.3 Europe Hospital-acquired Urinary Tract Infection Testing by End User

8 Asia Pacific

• 8.1 Asia Pacific Hospital-acquired Urinary Tract Infection Testing by Countries
  • 8.1.1 Asia Pacific Hospital-acquired Urinary Tract Infection Testing Sales by Countries
  • 8.1.2 Asia Pacific Hospital-acquired Urinary Tract Infection Testing Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Hospital-acquired Urinary Tract Infection Testing by Product
• 8.3 Asia Pacific Hospital-acquired Urinary Tract Infection Testing by End User

9 Central & South America

• 9.1 Central & South America Hospital-acquired Urinary Tract Infection Testing by Countries
  • 9.1.1 Central & South America Hospital-acquired Urinary Tract Infection Testing Sales by Countries
  • 9.1.2 Central & South America Hospital-acquired Urinary Tract Infection Testing Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Hospital-acquired Urinary Tract Infection Testing by Product
• 9.3 Central & South America Hospital-acquired Urinary Tract Infection Testing by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing by Countries
  • 10.1.1 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Sales by Countries
  • 10.1.2 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing by Product
• 10.3 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing by End User

11 Company Profiles

• 11.1 bioMérieux
  • 11.1.1 bioMérieux Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 bioMérieux Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 bioMérieux Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.1.5 bioMérieux Recent Development
• 11.2 Roche Diagnostics
  • 11.2.1 Roche Diagnostics Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.2.5 Roche Diagnostics Recent Development
• 11.3 Siemens Healthineer
  • 11.3.1 Siemens Healthineer Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.3.5 Siemens Healthineer Recent Development
• 11.4 ACON Laboratories
  • 11.4.1 ACON Laboratories Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.4.5 ACON Laboratories Recent Development
• 11.5 Alere
  • 11.5.1 Alere Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Alere Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Alere Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.5.5 Alere Recent Development
• 11.6 ARKRAY
  • 11.6.1 ARKRAY Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 ARKRAY Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 ARKRAY Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.6.5 ARKRAY Recent Development
• 11.7 Beckman Coulter
  • 11.7.1 Beckman Coulter Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.7.5 Beckman Coulter Recent Development
• 11.8 Becton Dickinson
  • 11.8.1 Becton Dickinson Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.8.5 Becton Dickinson Recent Development
• 11.9 Bio-Rad
  • 11.9.1 Bio-Rad Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.9.5 Bio-Rad Recent Development
• 11.10 Cepheid
  • 11.10.1 Cepheid Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Cepheid Hospital-acquired Urinary Tract Infection Testing Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Cepheid Hospital-acquired Urinary Tract Infection Testing Products Offered
  • 11.10.5 Cepheid Recent Development

12 Future Forecast

• 12.1 Hospital-acquired Urinary Tract Infection Testing Market Forecast by Regions
  • 12.1.1 Global Hospital-acquired Urinary Tract Infection Testing Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Forecast by Regions 2019-2025
• 12.2 Hospital-acquired Urinary Tract Infection Testing Market Forecast by Product
  • 12.2.1 Global Hospital-acquired Urinary Tract Infection Testing Sales Forecast by Product 2019-2025
  • 12.2.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Forecast by Product 2019-2025
• 12.3 Hospital-acquired Urinary Tract Infection Testing Market Forecast by End User
• 12.4 North America Hospital-acquired Urinary Tract Infection Testing Forecast
• 12.5 Europe Hospital-acquired Urinary Tract Infection Testing Forecast
• 12.6 Asia Pacific Hospital-acquired Urinary Tract Infection Testing Forecast
• 12.7 Central & South America Hospital-acquired Urinary Tract Infection Testing Forecast
• 12.8 Middle East and Africa Hospital-acquired Urinary Tract Infection Testing Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Hospital-acquired Urinary Tract Infection Testing Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details